Vertebroplasty & Kyphoplasty Market Size(US$)

CAGR 2025-2031
3.4%
Market Size,2031
USD 1,670
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
Market Segmentation
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Vertebroplasty & Kyphoplasty company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Vertebroplasty & Kyphoplasty Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Vertebroplastic Device
1.2.3 Kyphoplastic Device
1.3 Market by Application
1.3.1 Global Vertebroplasty & Kyphoplasty Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Vertebroplasty & Kyphoplasty Market Perspective (2020-2031)
2.2 Global Vertebroplasty & Kyphoplasty Growth Trends by Region
2.2.1 Global Vertebroplasty & Kyphoplasty Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Vertebroplasty & Kyphoplasty Historic Market Size by Region (2020-2025)
2.2.3 Vertebroplasty & Kyphoplasty Forecasted Market Size by Region (2026-2031)
2.3 Vertebroplasty & Kyphoplasty Market Dynamics
2.3.1 Vertebroplasty & Kyphoplasty Industry Trends
2.3.2 Vertebroplasty & Kyphoplasty Market Drivers
2.3.3 Vertebroplasty & Kyphoplasty Market Challenges
2.3.4 Vertebroplasty & Kyphoplasty Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Vertebroplasty & Kyphoplasty Players by Revenue
3.1.1 Global Top Vertebroplasty & Kyphoplasty Players by Revenue (2020-2025)
3.1.2 Global Vertebroplasty & Kyphoplasty Revenue Market Share by Players (2020-2025)
3.2 Global Vertebroplasty & Kyphoplasty Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Vertebroplasty & Kyphoplasty Revenue
3.4 Global Vertebroplasty & Kyphoplasty Market Concentration Ratio
3.4.1 Global Vertebroplasty & Kyphoplasty Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Vertebroplasty & Kyphoplasty Revenue in 2024
3.5 Global Key Players of Vertebroplasty & Kyphoplasty Head office and Area Served
3.6 Global Key Players of Vertebroplasty & Kyphoplasty, Product and Application
3.7 Global Key Players of Vertebroplasty & Kyphoplasty, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Vertebroplasty & Kyphoplasty Breakdown Data by Type
4.1 Global Vertebroplasty & Kyphoplasty Historic Market Size by Type (2020-2025)
4.2 Global Vertebroplasty & Kyphoplasty Forecasted Market Size by Type (2026-2031)
5 Vertebroplasty & Kyphoplasty Breakdown Data by Application
5.1 Global Vertebroplasty & Kyphoplasty Historic Market Size by Application (2020-2025)
5.2 Global Vertebroplasty & Kyphoplasty Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Vertebroplasty & Kyphoplasty Market Size (2020-2031)
6.2 North America Vertebroplasty & Kyphoplasty Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Vertebroplasty & Kyphoplasty Market Size by Country (2020-2025)
6.4 North America Vertebroplasty & Kyphoplasty Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Vertebroplasty & Kyphoplasty Market Size (2020-2031)
7.2 Europe Vertebroplasty & Kyphoplasty Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Vertebroplasty & Kyphoplasty Market Size by Country (2020-2025)
7.4 Europe Vertebroplasty & Kyphoplasty Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Vertebroplasty & Kyphoplasty Market Size (2020-2031)
8.2 Asia-Pacific Vertebroplasty & Kyphoplasty Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Vertebroplasty & Kyphoplasty Market Size by Region (2020-2025)
8.4 Asia-Pacific Vertebroplasty & Kyphoplasty Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Vertebroplasty & Kyphoplasty Market Size (2020-2031)
9.2 Latin America Vertebroplasty & Kyphoplasty Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Vertebroplasty & Kyphoplasty Market Size by Country (2020-2025)
9.4 Latin America Vertebroplasty & Kyphoplasty Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Vertebroplasty & Kyphoplasty Market Size (2020-2031)
10.2 Middle East & Africa Vertebroplasty & Kyphoplasty Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Vertebroplasty & Kyphoplasty Market Size by Country (2020-2025)
10.4 Middle East & Africa Vertebroplasty & Kyphoplasty Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Depuy Synthes
11.1.1 Depuy Synthes Company Details
11.1.2 Depuy Synthes Business Overview
11.1.3 Depuy Synthes Vertebroplasty & Kyphoplasty Introduction
11.1.4 Depuy Synthes Revenue in Vertebroplasty & Kyphoplasty Business (2020-2025)
11.1.5 Depuy Synthes Recent Development
11.2 Stryker Corporation
11.2.1 Stryker Corporation Company Details
11.2.2 Stryker Corporation Business Overview
11.2.3 Stryker Corporation Vertebroplasty & Kyphoplasty Introduction
11.2.4 Stryker Corporation Revenue in Vertebroplasty & Kyphoplasty Business (2020-2025)
11.2.5 Stryker Corporation Recent Development
11.3 CareFusion Corporation
11.3.1 CareFusion Corporation Company Details
11.3.2 CareFusion Corporation Business Overview
11.3.3 CareFusion Corporation Vertebroplasty & Kyphoplasty Introduction
11.3.4 CareFusion Corporation Revenue in Vertebroplasty & Kyphoplasty Business (2020-2025)
11.3.5 CareFusion Corporation Recent Development
11.4 Osseon LLC.
11.4.1 Osseon LLC. Company Details
11.4.2 Osseon LLC. Business Overview
11.4.3 Osseon LLC. Vertebroplasty & Kyphoplasty Introduction
11.4.4 Osseon LLC. Revenue in Vertebroplasty & Kyphoplasty Business (2020-2025)
11.4.5 Osseon LLC. Recent Development
11.5 Alphatec Spine, Inc.
11.5.1 Alphatec Spine, Inc. Company Details
11.5.2 Alphatec Spine, Inc. Business Overview
11.5.3 Alphatec Spine, Inc. Vertebroplasty & Kyphoplasty Introduction
11.5.4 Alphatec Spine, Inc. Revenue in Vertebroplasty & Kyphoplasty Business (2020-2025)
11.5.5 Alphatec Spine, Inc. Recent Development
11.6 TAEYEON MEDICAL Co., Ltd.
11.6.1 TAEYEON MEDICAL Co., Ltd. Company Details
11.6.2 TAEYEON MEDICAL Co., Ltd. Business Overview
11.6.3 TAEYEON MEDICAL Co., Ltd. Vertebroplasty & Kyphoplasty Introduction
11.6.4 TAEYEON MEDICAL Co., Ltd. Revenue in Vertebroplasty & Kyphoplasty Business (2020-2025)
11.6.5 TAEYEON MEDICAL Co., Ltd. Recent Development
11.7 G-21 S.R.L
11.7.1 G-21 S.R.L Company Details
11.7.2 G-21 S.R.L Business Overview
11.7.3 G-21 S.R.L Vertebroplasty & Kyphoplasty Introduction
11.7.4 G-21 S.R.L Revenue in Vertebroplasty & Kyphoplasty Business (2020-2025)
11.7.5 G-21 S.R.L Recent Development
11.8 BMK Global Medical Company
11.8.1 BMK Global Medical Company Company Details
11.8.2 BMK Global Medical Company Business Overview
11.8.3 BMK Global Medical Company Vertebroplasty & Kyphoplasty Introduction
11.8.4 BMK Global Medical Company Revenue in Vertebroplasty & Kyphoplasty Business (2020-2025)
11.8.5 BMK Global Medical Company Recent Development
11.9 Medtronic, Inc.,
11.9.1 Medtronic, Inc., Company Details
11.9.2 Medtronic, Inc., Business Overview
11.9.3 Medtronic, Inc., Vertebroplasty & Kyphoplasty Introduction
11.9.4 Medtronic, Inc., Revenue in Vertebroplasty & Kyphoplasty Business (2020-2025)
11.9.5 Medtronic, Inc., Recent Development
11.10 Globus Medical, Inc
11.10.1 Globus Medical, Inc Company Details
11.10.2 Globus Medical, Inc Business Overview
11.10.3 Globus Medical, Inc Vertebroplasty & Kyphoplasty Introduction
11.10.4 Globus Medical, Inc Revenue in Vertebroplasty & Kyphoplasty Business (2020-2025)
11.10.5 Globus Medical, Inc Recent Development
11.11 SOMATEX
11.11.1 SOMATEX Company Details
11.11.2 SOMATEX Business Overview
11.11.3 SOMATEX Vertebroplasty & Kyphoplasty Introduction
11.11.4 SOMATEX Revenue in Vertebroplasty & Kyphoplasty Business (2020-2025)
11.11.5 SOMATEX Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
Table of Figures
List of Tables
List of Figures
Related Reports
Vertebroplasty & Kyphoplasty are minimally invasive, image guided surgical procedures performed to treat the Vertebral Compression Fracture (VCF). VCFs can lead to back pain, reduced physical activity, depression, loss of independence, decreased lung capacity, and difficulty sleeping. Bone cement is injected into the back bone (vertebra) to provide support to the broken bone. Due to osteoporosis, vascular malformatins or, less commonly, cancer fractures can be caused in the vertebra. Vertebroplasty & Kyphoplasty help the patient to regain the functional abilities and avoid further vertebral collapse. Kyphoplasty is an advanced version of Vertebroplasty which can stabilize the fracture, restore heights and reduce deformities. The report studies the vertebroplasty and kyphoplasty devices market.
Published Date: 2024-01-16
Pages: 88
USD 2900.00
(Single User License)
Vertebroplasty & Kyphoplasty are minimally invasive, image guided surgical procedures performed to treat the Vertebral Compression Fracture (VCF). VCFs can lead to back pain, reduced physical activity, depression, loss of independence, decreased lung capacity, and difficulty sleeping. Bone cement is injected into the back bone (vertebra) to provide support to the broken bone. Due to osteoporosis, vascular malformatins or, less commonly, cancer fractures can be caused in the vertebra. Vertebroplasty & Kyphoplasty help the patient to regain the functional abilities and avoid further vertebral collapse. Kyphoplasty is an advanced version of Vertebroplasty which can stabilize the fracture, restore heights and reduce deformities. The report studies the vertebroplasty and kyphoplasty devices market.
Published Date: 2024-01-24
Pages: 110
USD 3950.00
(Single User License)
Vertebroplasty & Kyphoplasty are minimally invasive, image guided surgical procedures performed to treat the Vertebral Compression Fracture (VCF). VCFs can lead to back pain, reduced physical activity, depression, loss of independence, decreased lung capacity, and difficulty sleeping. Bone cement is injected into the back bone (vertebra) to provide support to the broken bone. Due to osteoporosis, vascular malformatins or, less commonly, cancer fractures can be caused in the vertebra. Vertebroplasty & Kyphoplasty help the patient to regain the functional abilities and avoid further vertebral collapse. Kyphoplasty is an advanced version of Vertebroplasty which can stabilize the fracture, restore heights and reduce deformities. The report studies the vertebroplasty and kyphoplasty devices market.
Published Date: 2024-04-12
Pages: 108
USD 4900.00
(Single User License)
The global market for Vertebroplasty & Kyphoplasty was estimated to be worth US$ 1323 million in 2024 and is forecast to a readjusted size of US$ 1670 million by 2031 with a CAGR of 3.4% during the forecast period 2025-2031.
Published Date: 2025-02-27
Pages: 111
USD 3950.00
(Single User License)
The global Vertebroplasty & Kyphoplasty market size was US$ 1323 million in 2024 and is forecast to a readjusted size of US$ 1670 million by 2031 with a CAGR of 3.4% during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 94
USD 4250.00
(Single User License)
The global Vertebroplasty & Kyphoplasty market was valued at US$ 1363 million in 2025 and is anticipated to reach US$ 1722 million by 2032, at a CAGR of 3.4% from 2026 to 2032.
Published Date: 2026-04-27
Pages: 117
USD 2900.00
(Single User License)
The global market for Vertebroplasty & Kyphoplasty was estimated to be worth US$ 1363 million in 2025 and is projected to reach US$ 1722 million, growing at a CAGR of 3.4% from 2026 to 2032.
Published Date: 2026-07-14
Pages: 120
USD 3950.00
(Single User License)
Vertebroplasty & Kyphoplasty are minimally invasive, image guided surgical procedures performed to treat the Vertebral Compression Fracture (VCF). VCFs can lead to back pain, reduced physical activity, depression, loss of independence, decreased lung capacity, and difficulty sleeping. Bone cement is injected into the back bone (vertebra) to provide support to the broken bone. Due to osteoporosis, vascular malformatins or, less commonly, cancer fractures can be caused in the vertebra. Vertebroplasty & Kyphoplasty help the patient to regain the functional abilities and avoid further vertebral collapse. Kyphoplasty is an advanced version of Vertebroplasty which can stabilize the fracture, restore heights and reduce deformities. The report studies the vertebroplasty and kyphoplasty devices market.
Published: 2024-01-16
Pages: 88
Vertebroplasty & Kyphoplasty are minimally invasive, image guided surgical procedures performed to treat the Vertebral Compression Fracture (VCF). VCFs can lead to back pain, reduced physical activity, depression, loss of independence, decreased lung capacity, and difficulty sleeping. Bone cement is injected into the back bone (vertebra) to provide support to the broken bone. Due to osteoporosis, vascular malformatins or, less commonly, cancer fractures can be caused in the vertebra. Vertebroplasty & Kyphoplasty help the patient to regain the functional abilities and avoid further vertebral collapse. Kyphoplasty is an advanced version of Vertebroplasty which can stabilize the fracture, restore heights and reduce deformities. The report studies the vertebroplasty and kyphoplasty devices market.
Published: 2024-01-24
Pages: 110
Vertebroplasty & Kyphoplasty are minimally invasive, image guided surgical procedures performed to treat the Vertebral Compression Fracture (VCF). VCFs can lead to back pain, reduced physical activity, depression, loss of independence, decreased lung capacity, and difficulty sleeping. Bone cement is injected into the back bone (vertebra) to provide support to the broken bone. Due to osteoporosis, vascular malformatins or, less commonly, cancer fractures can be caused in the vertebra. Vertebroplasty & Kyphoplasty help the patient to regain the functional abilities and avoid further vertebral collapse. Kyphoplasty is an advanced version of Vertebroplasty which can stabilize the fracture, restore heights and reduce deformities. The report studies the vertebroplasty and kyphoplasty devices market.
Published: 2024-04-12
Pages: 108
The global market for Vertebroplasty & Kyphoplasty was estimated to be worth US$ 1323 million in 2024 and is forecast to a readjusted size of US$ 1670 million by 2031 with a CAGR of 3.4% during the forecast period 2025-2031.
Published: 2025-02-27
Pages: 111
The global Vertebroplasty & Kyphoplasty market size was US$ 1323 million in 2024 and is forecast to a readjusted size of US$ 1670 million by 2031 with a CAGR of 3.4% during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 94
The global Vertebroplasty & Kyphoplasty market was valued at US$ 1363 million in 2025 and is anticipated to reach US$ 1722 million by 2032, at a CAGR of 3.4% from 2026 to 2032.
Published: 2026-04-27
Pages: 117
The global market for Vertebroplasty & Kyphoplasty was estimated to be worth US$ 1363 million in 2025 and is projected to reach US$ 1722 million, growing at a CAGR of 3.4% from 2026 to 2032.
Published: 2026-07-14
Pages: 120
REPORT COVERAGE
Market Segmentation
Why This Report?
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
Interest In This Report?
Get A Free Sample
Pre-Order Enquiry
OR
Need a Tailored Report?
Customize this report to your needs.
Customize This Report
Fact Checked
Cite this Research